EP3932951
AÐFERÐIR Í MEÐFERÐ VIÐ HÚÐKRABBA MEÐ AÐ GEFA PD-1-HEMIL
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.5.2017EP published:
7.12.2022EP application number:
21191931.1
EP translation filed:
16.2.2023Grant published:
15.4.2023EPO information:
European Patent Register
Max expiry date:
11.5.2037Expiry date:
11.5.2026Next due date:
31.5.2026
Title in English:
METHODS OF TREATING SKIN CANCER BY ADMINISTERING A PD-1 INHIBITORLanguage of the patent:
English
Timeline
Today
12.5.2017EP application
7.12.2022EP Publication
16.2.2023Translation submitted
15.4.2023Registration published
11.5.2026Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Inventor
Name:
LOWY, IsraelAddress:
New York 10591, US
Name:
FURY, Matthew, G.Address:
New York 10591, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201662335743 PDate:
13.5.2016Country:
US
Number:
201662340142 PDate:
23.5.2016Country:
US
Number:
201662348546 PDate:
10.6.2016Country:
US
Number:
201662350305 PDate:
15.6.2016Country:
US
Number:
201662364920 PDate:
21.7.2016Country:
US
Number:
201662374020 PDate:
12.8.2016Country:
US
Number:
201762451274 PDate:
27.1.2017Country:
US
Classification
Categories:
C07K 16/28, A61N 5/00, A61N 5/10
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 22.4.2023
Expires: 11.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 19.4.2024
Expires: 11.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.5.2025
Expires: 11.5.2026
Payer: Árnason Faktor ehf.